BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25814167)

  • 1. Lipoxins exert antiangiogenic and anti-inflammatory effects on Kaposi's sarcoma cells.
    Marginean A; Sharma-Walia N
    Transl Res; 2015 Aug; 166(2):111-33. PubMed ID: 25814167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
    Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
    FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN; Chiang N
    ScientificWorldJournal; 2002 Jan; 2():169-204. PubMed ID: 12806051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.
    Asha K; Balfe N; Sharma-Walia N
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32102879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
    J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway lipoxin A4/formyl peptide receptor 2-lipoxin receptor levels in pediatric patients with severe asthma.
    Gagliardo R; Gras D; La Grutta S; Chanez P; Di Sano C; Albano GD; Vachier I; Montalbano AM; Anzalone G; Bonanno A; Riccobono L; Gjomarkaj M; Profita M
    J Allergy Clin Immunol; 2016 Jun; 137(6):1796-1806. PubMed ID: 26971688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
    Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
    Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
    Lv W; Lv C; Yu S; Yang Y; Kong H; Xie J; Sun H; Andersson R; Xu D; Chen B; Zhou M
    Exp Biol Med (Maywood); 2013 Dec; 238(12):1388-95. PubMed ID: 24000382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
    Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
    Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells.
    Marchiò S; Primo L; Pagano M; Palestro G; Albini A; Veikkola T; Cascone I; Alitalo K; Bussolino F
    J Biol Chem; 1999 Sep; 274(39):27617-22. PubMed ID: 10488101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin A4 attenuates brain damage and downregulates the production of pro-inflammatory cytokines and phosphorylated mitogen-activated protein kinases in a mouse model of traumatic brain injury.
    Luo CL; Li QQ; Chen XP; Zhang XM; Li LL; Li BX; Zhao ZQ; Tao LY
    Brain Res; 2013 Mar; 1502():1-10. PubMed ID: 23370001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
    Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion.
    Sharma-Walia N; Paul AG; Bottero V; Sadagopan S; Veettil MV; Kerur N; Chandran B
    PLoS Pathog; 2010 Feb; 6(2):e1000777. PubMed ID: 20169190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
    Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
    J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxin receptors.
    Romano M; Recchia I; Recchiuti A
    ScientificWorldJournal; 2007 Sep; 7():1393-412. PubMed ID: 17767357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor.
    Cezar-de-Mello PF; Vieira AM; Nascimento-Silva V; Villela CG; Barja-Fidalgo C; Fierro IM
    Br J Pharmacol; 2008 Mar; 153(5):956-65. PubMed ID: 18193074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.